Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Benmelstobart”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07627464
What this trial is testing

Anlotinib + Benmelstobart vs Surgery for Patients With Localized Renal Cell Carcinoma Scheduled to Undergo Partial Nephrectomy

Who this might be right for
Renal Cell Carcinoma (RCC)
Tianjin Medical University Cancer Institute and Hospital 144
Testing effectiveness (Phase 2)Looking for participantsNCT06733051
What this trial is testing

Phase II Study of Golidocitinib and Benmelstobart in Patients with R/R ENKTL (JACKPOT50)

Who this might be right for
Natural Killer T-cell Lymphoma
Sun Yat-sen University 47
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07643350
What this trial is testing

Efficacy and Safety of Induction Benmelstobart Plus Anlotinib and Chemotherapy Followed by Concurrent Chemoradiotherapy and Benmelstobart Maintenance Versus Concurrent Chemoradiotherapy Followed by Benmelstobart Maintenance in Patients With Unresectable Stage III NSCLC

Who this might be right for
NSCLC
The Third Xiangya Hospital of Central South University 152
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07510594
What this trial is testing

A Phase II Study of Benmelstobart + Anlotinib + Chemotherapy as First-Line Treatment for LCNEC and EP-NEC

Who this might be right for
Large-Cell Neuroendocrine Carcinoma of the LungExtrapulmonary Neuroendocrine Carcinoma
Tianjin Medical University Cancer Institute and Hospital 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06621095
What this trial is testing

Anlotinib Plus Benmelstobart and AG in First-line Treatment of Advanced Metastatic Pancreatic Cancer (ALTER-PA-001)

Who this might be right for
Pancreatic CancerFirst-lineMetastatic Pancreatic Cancer
RenJi Hospital 104
Testing effectiveness (Phase 2)Looking for participantsNCT06637163
What this trial is testing

Benmelstobart Combined With Radiochemotherapy as Neoadjuvant Treatment Iin ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital 100
Large-scale testing (Phase 3)Looking for participantsNCT07445048
What this trial is testing

Postoperative Radiotherapy Combined With Nimotuzumab Followed by Benmelstobart in High-Risk Patients With Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head & Neck Squamous Cell CarcinomaHead & Neck CancerPostoperative Adjuvant Treatment
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 370
Testing effectiveness (Phase 2)Looking for participantsNCT07806292
What this trial is testing

Anlotinib + Benmelstobart + HAIC in Unresectable HCC: A Phase II Study

Who this might be right for
Unresectable Hepatocellular Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06978153
What this trial is testing

This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart Combined With Chemotherapy With or Without Anlotinib in Resectable Limited-Stage Small Cell Lung Cancer

Who this might be right for
Limited Stage Small Cell Lung Cancer
Tang-Du Hospital 66
Post-approval studies (Phase 4)Not Yet RecruitingNCT06931145
What this trial is testing

Benmelstobart, Anlotinib and Chemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Peking Union Medical College Hospital 50